Enlarged Pores
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults aged 18-60 years with enlarged facial pores; 2. The area and severity of enlarged pores should be in similar severity on both sides of face; 3. Subjects should sign the informed consent, and be willing to comply with the trial treatment, follow-up and evaluation requirements.
Exclusion criteria
Exclusion criteria: 1. Those who have received treatments such as laser, intense pulse light, chemical peeling and fillers in the treatment area within one year; 2. Smokers; 3. People with scar or skin diseases (such as vitiligo, lichen planus, etc.) that can easily induce Koebner phenomenon; 4. Without control of other facial skin diseases, or a history of facial herpes simplex, varicella zoster virus infection, or a history of skin tumors, discoid lupus erythematosus and other serious skin diseases; 5. Those who have been treated with systemic retinoic acid in the past three months, minocycline, quinolone and other photosensitive drugs in the past one month, or those who have photosensitive history; 6. Darkening of facial skin due to recent exposure; 7. Pregnant women, lactation, or have serious diseases such as cardiac and cerebrovascular, liver and kidney dysfunction; or the person that installs pacemaker, defibrillator; 8. Patients with mental illness or other potential reasons who cannot complete treatment and follow-up plans; 9. Participated in other clinical trials in recent 1 month; 10. Other conditions that may result in adverse outcomes for patients; 11. Pigmented diseases, acne or other skin diseases in the treatment area that may interfere the evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of pores; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sebum;TEWL; | — |
Countries
China
Contacts
Huashan Hospital affiliated to Fudan University